Miramar Hotel & Investment Co. Ltd. (71) : Company Profile and SWOT Analysis

World Market Intelligence
May 29, 2014
33 Pages - SKU: WLMI5257292
Midstates Petroleum Co Inc (MPO: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
10/14/2014 | published by: Plunkett Research, Ltd.
Midstates Petroleum Co Inc (MPO: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for (Midstates Petroleum Co Inc, MPO: NYS) compared  |  read more...
USD 1,795
Murphy Oil Corporation (MUR: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
10/14/2014 | published by: Plunkett Research, Ltd.
Murphy Oil Corporation (MUR: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for (Murphy Oil Corporation, MUR: NYS) compared to its  |  read more...
USD 1,795
Medisyn Technologies, Inc. - Product Pipeline Review - 2014
10/25/2014 | published by: Global Markets Direct
Medisyn Technologies, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Medisyn Technologies, Inc. - Product Pipeline Review - 2014’, provides an overview of the Medisyn Technologies, Inc.’s pharmaceutical research and development focus. This report provides  |  read more...
USD 1,500
Medestea Research & Production S.p.A. - Product Pipeline Review - 2014
10/25/2014 | published by: Global Markets Direct
Medestea Research & Production S.p.A. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Medestea Research & Production S.p.A. - Product Pipeline Review - 2014’, provides an overview of the Medestea Research & Production S.p.A.’s pharmaceutical  |  read more...
USD 1,500
miRagen Therapeutics, Inc. - Product Pipeline Review - 2014
10/25/2014 | published by: Global Markets Direct
miRagen Therapeutics, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘miRagen Therapeutics, Inc. - Product Pipeline Review - 2014’, provides an overview of the miRagen Therapeutics, Inc.’s pharmaceutical research and development focus. This report provides  |  read more...
USD 1,500
Morphotek, Inc. - Product Pipeline Review - 2014
10/25/2014 | published by: Global Markets Direct
Morphotek, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Morphotek, Inc. - Product Pipeline Review - 2014’, provides an overview of the Morphotek, Inc.’s pharmaceutical research and development focus. This report provides comprehensive information on  |  read more...
USD 1,500
Marathon Oil Corp (MRO: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
10/14/2014 | published by: Plunkett Research, Ltd.
Marathon Oil Corp (MRO: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for (Marathon Oil Corp, MRO: NYS) compared to its  |  read more...
USD 1,795
Molecular Partners AG - Product Pipeline Review - 2014
10/25/2014 | published by: Global Markets Direct
Molecular Partners AG - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Molecular Partners AG - Product Pipeline Review - 2014’, provides an overview of the Molecular Partners AG’s pharmaceutical research and development focus. This report provides  |  read more...
USD 1,500
Merus B.V. - Product Pipeline Review - 2014
10/25/2014 | published by: Global Markets Direct
Merus B.V. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Merus B.V. - Product Pipeline Review - 2014’, provides an overview of the Merus B.V.’s pharmaceutical research and development focus. This report provides comprehensive information on  |  read more...
USD 1,500
Merck & Co Inc (MRK: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
10/27/2014 | published by: Plunkett Research, Ltd.
Merck & Co Inc (MRK: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for (Merck & Co Inc, MRK: NYS) compared  |  read more...
USD 1,795
 

SELECT A LICENSE

    Online Download  USD 125  
    Global Site License  USD 375  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!